226 related articles for article (PubMed ID: 12142073)
1. Alterations of DNA methylation in hematologic malignancies.
Rush LJ; Plass C
Cancer Lett; 2002 Nov; 185(1):1-12. PubMed ID: 12142073
[TBL] [Abstract][Full Text] [Related]
2. Gene silencing by DNA methylation in haematological malignancies.
Boultwood J; Wainscoat JS
Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
[TBL] [Abstract][Full Text] [Related]
3. Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg.
Esteller M
Clin Immunol; 2003 Oct; 109(1):80-8. PubMed ID: 14585279
[TBL] [Abstract][Full Text] [Related]
4. The role of DNA hypermethylation in the pathogenesis and prognosis of acute lymphoblastic leukemia.
Roman-Gomez J; Castillejo JA; Jimenez A; Barrios M; Heiniger A; Torres A
Leuk Lymphoma; 2003 Nov; 44(11):1855-64. PubMed ID: 14738136
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
7. Promoter-region hypermethylation and gene silencing in human cancer.
Herman JG; Baylin SB
Curr Top Microbiol Immunol; 2000; 249():35-54. PubMed ID: 10802937
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation.
Corn PG; Kuerbitz SJ; van Noesel MM; Esteller M; Compitello N; Baylin SB; Herman JG
Cancer Res; 1999 Jul; 59(14):3352-6. PubMed ID: 10416592
[TBL] [Abstract][Full Text] [Related]
9. CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells.
Opavsky R; Wang SH; Trikha P; Raval A; Huang Y; Wu YZ; Rodriguez B; Keller B; Liyanarachchi S; Wei G; Davuluri RV; Weinstein M; Felsher D; Ostrowski M; Leone G; Plass C
PLoS Genet; 2007 Sep; 3(9):1757-69. PubMed ID: 17907813
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation and cancer.
Kulis M; Esteller M
Adv Genet; 2010; 70():27-56. PubMed ID: 20920744
[TBL] [Abstract][Full Text] [Related]
12. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
Esteller M
Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of gene promoters in hematological neoplasia.
Chim CS; Liang R; Kwong YL
Hematol Oncol; 2002 Dec; 20(4):167-76. PubMed ID: 12469326
[TBL] [Abstract][Full Text] [Related]
14. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer.
Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K
Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533
[TBL] [Abstract][Full Text] [Related]
15. Silencing of bidirectional promoters by DNA methylation in tumorigenesis.
Shu J; Jelinek J; Chang H; Shen L; Qin T; Chung W; Oki Y; Issa JP
Cancer Res; 2006 May; 66(10):5077-84. PubMed ID: 16707430
[TBL] [Abstract][Full Text] [Related]
16. DNA hypermethylation: when tumour suppressor genes go silent.
Garinis GA; Patrinos GP; Spanakis NE; Menounos PG
Hum Genet; 2002 Aug; 111(2):115-27. PubMed ID: 12189484
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA Methylation in Colorectal Cancer.
Kaur S; Lotsari-Salomaa JE; Seppänen-Kaijansinkko R; Peltomäki P
Adv Exp Med Biol; 2016; 937():109-22. PubMed ID: 27573897
[TBL] [Abstract][Full Text] [Related]
18. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation changes in leukaemia.
Melki JR; Clark SJ
Semin Cancer Biol; 2002 Oct; 12(5):347-57. PubMed ID: 12191634
[TBL] [Abstract][Full Text] [Related]
20. [Promoter hypermethylation and CpG island methylator phenotype in colorectal carcinogenesis].
Matsubara N
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1659-64. PubMed ID: 20841928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]